Data Integrity refers to the completeness, consistency, accuracy, and reliability of data throughout its lifecycle, ensuring information remains trustworthy from initial generation through processing, reporting, and long-term storage. This principle underpins regulatory compliance and scientific credibility, requiring that data be attributable, legible, contemporaneous, original, and accurate, commonly summarised through ALCOA and expanded ALCOA+ frameworks. Data integrity applies across laboratory records, manufacturing batch documentation, clinical trial datasets, and electronic systems supporting regulated activities.
The pharmaceutical industry treats data integrity as a foundational quality requirement, with regulatory inspections focusing heavily on whether records accurately reflect performed work and whether systems prevent manipulation, loss, or unauthorised changes. Controls include audit trails, access management, validated computer systems, secure backups, and robust procedural oversight ensuring traceable decision-making. Data integrity failures can result in warning letters, batch rejection, delayed approvals, or significant reputational damage. As digital transformation accelerates through automation, electronic batch records, and cloud-based platforms, data integrity programmes continue evolving to manage increasing complexity while ensuring regulatory confidence and protecting patient safety.
General Biopharmaceutical Concepts
Data Integrity
Data integrity is the assurance that data remain complete, accurate, consistent and reliable throughout their entire lifecycle.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →